Analysis of Thromboinflammatory and Oxidative Stress Biomarkers in Patients with ESRD

Background: Atrial fibrillation (AF) is a frequent comorbid condition in patients with end-stage renal disease (ESRD). AF presents thromboembolic risk, and loss of renal function in ESRD causes susceptibility to increasing oxidative stress level. Endothelial dysregulation may contribute to molecular and cellular imbalance involved in AF and be exacerbated with ESRD, illustrated by increased levels of circulating endothelial, inflammatory, and oxidative stress biomarkers. Methods: The study determines the differences between thrombo-inflammatory and oxidative stress biomarkers in ESRD patients with and without comorbid AF. Banked ESRD plasma samples were selected to identify patients with and without AF. Validated ELISA and appropriate statistical methods were used to profile the biomarkers and clinical correlates. Results: EPIC analysis reveals that the AF group has greater representation of male, black, and older patients than the non-AF group. Additionally, AF patients have higher comorbidity counts for disease states such as DVT, PE, and MI, and higher lab levels of liver enzymes, such as AST, ALP, ASP, and bilirubin. Initial analysis shows statistically significant difference in many thrombo-inflammatory and oxidative stress biomarker levels, such as thrombomodulin, in ESRD patients with and without AF, as well as moderate correlations between various biomarkers. Conclusion: ESRD patients with and without AF show high levels of thromboinflammatory and oxidative stress biomarkers. Moderate correlation between these biomarkers indicates relation between the two disease processes. The differences in correlation between various biomarkers for the two patient groups lends to understanding of the disease processes separately and concurrently. This study will be useful in assessing the pathophysiology of these disease states by evaluating biomarker levels in ESRD patients with or without AF. Funding: Other NIH Support - NIH T35 Research Training Program

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025tr57m55c
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of Thromboinflammatory and Oxidative Stress Biomarkers in Patients with ESRD

Fakiha Siddiqui, Jawed Fareed, Luís Augusto Rohde, Debra Hoppensteadt et al.
Journal of the American Society of Nephrology
Venous Thromboembolism Diagnosis and Management
article

Analysis of Thromboinflammatory and Oxidative Stress Biomarkers in Patients with ESRD

Fakiha Siddiqui, Jawed Fareed, Luís Augusto Rohde, Debra Hoppensteadt, Kavitha Vellanki, Mushabbar Syed, Ella Kaufmann, Simran Koura, Vinod Bansal, Katherine Elizabeth Konczak
article en

Abstract

Background: Atrial fibrillation (AF) is a frequent comorbid condition in patients with end-stage renal disease (ESRD). AF presents thromboembolic risk, and loss of renal function in ESRD causes susceptibility to increasing oxidative stress level. Endothelial dysregulation may contribute to molecular and cellular imbalance involved in AF and be exacerbated with ESRD, illustrated by increased levels of circulating endothelial, inflammatory, and oxidative stress biomarkers. Methods: The study determines the differences between thrombo-inflammatory and oxidative stress biomarkers in ESRD patients with and without comorbid AF. Banked ESRD plasma samples were selected to identify patients with and without AF. Validated ELISA and appropriate statistical methods were used to profile the biomarkers and clinical correlates. Results: EPIC analysis reveals that the AF group has greater representation of male, black, and older patients than the non-AF group. Additionally, AF patients have higher comorbidity counts for disease states such as DVT, PE, and MI, and higher lab levels of liver enzymes, such as AST, ALP, ASP, and bilirubin. Initial analysis shows statistically significant difference in many thrombo-inflammatory and oxidative stress biomarker levels, such as thrombomodulin, in ESRD patients with and without AF, as well as moderate correlations between various biomarkers. Conclusion: ESRD patients with and without AF show high levels of thromboinflammatory and oxidative stress biomarkers. Moderate correlation between these biomarkers indicates relation between the two disease processes. The differences in correlation between various biomarkers for the two patient groups lends to understanding of the disease processes separately and concurrently. This study will be useful in assessing the pathophysiology of these disease states by evaluating biomarker levels in ESRD patients with or without AF. Funding: Other NIH Support - NIH T35 Research Training Program

Journal of the American Society of NephrologyVol. 36(10S)
Loyola University Medical Center (US)
Openalex Percentile: Top 41%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.